The FDA warned devicemaker Spineology for marketing its OptiMesh Deployable Grafting System without marketing clearance or approval.
According to the letter the FDA reviewed portions of the company’s website as well as a promotional DVD. “OptiMesh 1500 Surgical Video with QuikTrak,” which the company distributed at the North American Spine Society annual meeting in 2006.
“Both the website and the DVD promote the OptiMesh device for an intended use that requires submission of either a new premarket notification submission (510(k)) or an application for premarket approval,” the letter said.
A review of FDA records showed Spineology did not obtain marketing clearance before it began offering the OptiMesh for use in procedures requiring structural support the FDA said.
300 N. Washington St.. Suite 200. Falls Church. VA 22046. USA. Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
| © Copyright 2008 by FDAnewsAll rights reserved. Do not duplicate or redistribute in any form.
Related article:
http://www.fdanews.com/newsletter/article?articleId=98155&issueId=10689
comments | Add comment | Report as Spam
|